By the set cutoff value based on the ROC curve, the whole cohort of AML patients were divided into two groups, low HSPG2 expression (≤4.39) (HSPG2low) and high HSPG2 expression (>4.39) (HSPG2high). The gene discussed is HSPG2; the disease is acute myeloid leukemia.